2009
DOI: 10.1111/j.1552-6569.2008.00322.x
|View full text |Cite
|
Sign up to set email alerts
|

Measurement of Antiplatelet Inhibition during Neurointerventional Procedures: The Effect of Antithrombotic Duration and Loading Dose

Abstract: Premedication with clopidogrel, in contrast to aspirin, does not achieve adequate platelet inhibition in about two-third of the patients. Same day antiplatelet loading may be insufficient to achieve adequate platelet inhibition and should be avoided if clinically feasible.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
32
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(32 citation statements)
references
References 10 publications
0
32
0
Order By: Relevance
“…The efficacy of antiaggregational medication such as aspirin and clopidogrel is known to vary depending on the patient's drug susceptibility, as well as the dose and time of application. 7 Despite various treatment and prophylaxis algorithms, the rate of thromboembolic events remains high, suggesting that not only an improvement in technique and development of new embolic materials but also an optimization of drug intervention and monitoring is mandatory.…”
mentioning
confidence: 99%
“…The efficacy of antiaggregational medication such as aspirin and clopidogrel is known to vary depending on the patient's drug susceptibility, as well as the dose and time of application. 7 Despite various treatment and prophylaxis algorithms, the rate of thromboembolic events remains high, suggesting that not only an improvement in technique and development of new embolic materials but also an optimization of drug intervention and monitoring is mandatory.…”
mentioning
confidence: 99%
“…Up to 66% of patients with cerebrovascular disease have a reduced response to clopidogrel, [8][9][10][11] placing them at higher risk of thrombosis, 12 while 14.9%-38% of patients are hyper-responsive to clopidogrel. 13,14 Differing responses to clopidogrel may be related to CYP2C19 gene polymorphisms.…”
mentioning
confidence: 99%
“…Four case series were published in 2008 , MullerSchunk et al, 2008, Pandya et al, 2008, Prabhakaran et al, 2008. Only two have studied the incidence of thromboembolism using techniques and different cut-offs.…”
Section: Pre-operative Preparationmentioning
confidence: 99%